Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
April 24, 1997New England Journal of MedicineOpen Access

A Controlled Trial of Selegiline, Alpha-Tocopherol, or Both as Treatment for Alzheimer's Disease

View Full Paper
Ask AI
Bookmark
Share

Authors

MSMary SanoJames J. Peters VA Medical CenterCEChristopher ErnestoUniversity of Southern CaliforniaRTRonald G. ThomasUniversity of California, San Diego

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Sano et al. (1997) studied this question.

synapsesocial.com/papers/6a11cdec8b61bd91eb5638b8https://doi.org/10.1056/nejm199704243361704
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Assessing Patient Dependence in Alzheimer's Disease1994 · 165 citations
  2. 2Deprenyl (selegiline): the history of its development and pharmacological action1983 · 157 citations
  3. 3Effects of Tocopherol and Deprenyl on the Progression of Disability in Early Parkinson's Disease1993 · 1,227 citations
  4. 4Postischemic Cerebral Lipid Peroxidation In Vitro: Modification by Dietary Vitamin E1985 · 127 citations